Schrodinger (NASDAQ:SDGR) CFO Rachit Jain Sells 1,631 Shares of Stock

Schrodinger, Inc. (NASDAQ:SDGR) CFO Rachit Jain sold 1,631 shares of Schrodinger stock in a transaction dated Thursday, March 5th. The shares were sold at an average price of $12.90, for a total value of $21,039.90. Following the sale, the chief financial officer owned 52,596 shares of the company’s stock, valued at approximately $678,488.40. This represents a 3.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Schrodinger Stock Performance

Shares of NASDAQ SDGR traded down $0.29 during trading hours on Friday, hitting $12.74. The stock had a trading volume of 976,433 shares, compared to its average volume of 1,680,207. The firm’s 50-day moving average price is $14.77 and its two-hundred day moving average price is $17.59. Schrodinger, Inc. has a 52 week low of $11.11 and a 52 week high of $27.63. The company has a market capitalization of $938.56 million, a P/E ratio of -8.97 and a beta of 1.57.

Schrodinger (NASDAQ:SDGR) last posted its earnings results on Wednesday, February 25th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.57. The firm had revenue of $87.24 million during the quarter, compared to analysts’ expectations of $83.66 million. Schrodinger had a negative net margin of 40.37% and a negative return on equity of 29.47%. The company’s revenue was up 4.7% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.24) earnings per share. As a group, analysts expect that Schrodinger, Inc. will post -2.37 EPS for the current fiscal year.

Analyst Ratings Changes

SDGR has been the subject of a number of recent research reports. Wall Street Zen upgraded shares of Schrodinger from a “sell” rating to a “hold” rating in a report on Saturday, January 31st. TD Cowen reiterated a “buy” rating on shares of Schrodinger in a research note on Thursday, January 8th. Bank of America raised Schrodinger from a “neutral” rating to a “buy” rating and set a $24.00 price objective on the stock in a report on Monday, December 15th. UBS Group started coverage on Schrodinger in a research note on Wednesday, January 7th. They issued a “neutral” rating and a $18.00 price objective on the stock. Finally, KeyCorp reduced their target price on Schrodinger from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Thursday, January 8th. Four investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $21.75.

Trending Headlines about Schrodinger

Here are the key news stories impacting Schrodinger this week:

• Positive Sentiment: Yahoo Finance piece highlights an evolving investment thesis as Schrödinger shifts toward hosted software and resets targets, which could support longer-term sentiment if adoption and ARR trajectory improve. How The Schrödinger (SDGR) Investment Story Is Evolving With Hosted Software And Reset Targets
• Neutral Sentiment: Transcript from Schrödinger’s TD Cowen conference presentation provides management commentary and detail that investors can use to re-assess guidance, product roadmap and commercialization progress; useful but not an immediate catalyst. Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
• Negative Sentiment: CEO Ramy Farid sold 3,661 shares at an average $12.91 (≈1.09% reduction in his stake), a high-profile insider sale that can signal near-term selling pressure. CEO Form 4
• Negative Sentiment: CFO Rachit Jain sold 1,631 shares at ~$12.90 (≈3.01% reduction), adding to the cluster of exec sales that market participants often interpret as a negative signal. CFO Form 4
• Negative Sentiment: Other senior leaders (EVPs Kenneth Lorton and Yvonne Tran, CAO Jenny Herman, and insiders Robert Abel, Karen Akinsanya) executed small-to-moderate sales (roughly 600–1,366 shares each around $12.80–$12.91), collectively reducing insider holdings and contributing to downward pressure. Sample Insider Filing (Robert Abel)
• Negative Sentiment: Multiple filings show these sales occurred within a short window (Mar 4–6), which magnifies market reaction compared with isolated, scheduled sales; however, each sale is a small percentage of total insider stakes and could reflect diversification or option/vesting activity rather than a change in corporate outlook. SEC Filings

Institutional Investors Weigh In On Schrodinger

Hedge funds have recently bought and sold shares of the company. Amalgamated Bank grew its position in shares of Schrodinger by 3.9% in the third quarter. Amalgamated Bank now owns 16,411 shares of the company’s stock valued at $329,000 after purchasing an additional 623 shares during the last quarter. Verity Asset Management Inc. lifted its position in shares of Schrodinger by 1.2% during the 4th quarter. Verity Asset Management Inc. now owns 65,722 shares of the company’s stock worth $1,175,000 after purchasing an additional 798 shares during the last quarter. Bank of Montreal Can boosted its stake in Schrodinger by 5.8% during the 2nd quarter. Bank of Montreal Can now owns 15,941 shares of the company’s stock valued at $321,000 after purchasing an additional 879 shares during the period. Handelsbanken Fonder AB boosted its stake in Schrodinger by 6.3% during the 4th quarter. Handelsbanken Fonder AB now owns 15,200 shares of the company’s stock valued at $272,000 after purchasing an additional 900 shares during the period. Finally, Stephens Inc. AR grew its holdings in Schrodinger by 9.5% in the 3rd quarter. Stephens Inc. AR now owns 10,894 shares of the company’s stock valued at $219,000 after buying an additional 944 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

About Schrodinger

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.